Such studies are important because these diseases have both genetic and lifestyle factors that contribute to risk. The study has managed to cross the target of 10,000 samples.
Called 'Phenom India-CSIR Health Cohort Knowledgebase' (PI-CHECK), it is the first pan-India longitudinal study to enable better prediction models for cardio-metabolic diseases, liver diseases and cardiovascular diseases.
Dr Shantanu Sengupta, Senior Principal Scientist, CSIR-Institute of Genomics and Integrative Biology, said, despite the high burden of cardio-metabolic diseases in India, the reasons for such a high incidence in the population are not completely clear.
“Risk factors in the West may not be the same as risk factors in India. A factor that may be important for a particular person may not be important for another person. Hence the one-size-fits-all concept Will have to be adopted in our country,” he said at an event in Goa.
“Once we get around 1 lakh or 10 lakh samples, it will enable us to redefine all key parameters in the country,” Sengupta said.
CSIR has developed a cost effective standard operating procedure for sample collection.
The PI-CHECK project, launched on December 7, 2023, aims to assess the risk factors for non-communicable (cardio-metabolic) diseases within the Indian population. Experts said it is important to understand the mechanisms that underlie the increased risk and incidence of cardio-metabolic disorders in the Indian population and develop new strategies for risk stratification, prevention and management of these major diseases.
Called 'Phenom India-CSIR Health Cohort Knowledgebase' (PI-CHECK), it is the first pan-India longitudinal study to enable better prediction models for cardio-metabolic diseases, liver diseases and cardiovascular diseases.
Dr Shantanu Sengupta, Senior Principal Scientist, CSIR-Institute of Genomics and Integrative Biology, said, despite the high burden of cardio-metabolic diseases in India, the reasons for such a high incidence in the population are not completely clear.
“Risk factors in the West may not be the same as risk factors in India. A factor that may be important for a particular person may not be important for another person. Hence the one-size-fits-all concept Will have to be adopted in our country,” he said at an event in Goa.
“Once we get around 1 lakh or 10 lakh samples, it will enable us to redefine all key parameters in the country,” Sengupta said.
CSIR has developed a cost effective standard operating procedure for sample collection.
The PI-CHECK project, launched on December 7, 2023, aims to assess the risk factors for non-communicable (cardio-metabolic) diseases within the Indian population. Experts said it is important to understand the mechanisms that underlie the increased risk and incidence of cardio-metabolic disorders in the Indian population and develop new strategies for risk stratification, prevention and management of these major diseases.